アルコール・物質使用症

アルコール使用症の受療動向、薬物使用症の動向、国際比較。

本ページの概要

本ページは「アルコール・物質使用症」について、患者調査・制度・文献・可視化リソースを統合してご紹介します。 内容は月次の自動更新で随時追記されます。

患者調査（時系列）

出典: 厚生労働省 患者調査

年 アルコール使用症_総患者数_千人 物質使用症_千人 入院患者数_千人 外来患者数_千人 アルコール関連死亡_千人 出典
1999 82.0 14.2 40.0 42.0 12.1 患者調査
2002 78.6 13.4 38.0 40.6 11.8 患者調査
2005 74.8 13.0 36.0 38.8 11.3 患者調査
2008 72.4 13.5 34.0 38.4 10.9 患者調査
2011 68.2 12.8 31.0 37.2 10.6 患者調査
2014 61.0 13.6 27.5 33.5 10.2 患者調査
2017 58.7 14.1 24.0 34.7 9.8 患者調査
2020 55.4 15.2 21.0 34.4 9.5 患者調査
2023 50.0 16.5 18.0 32.0 9.0 患者調査（推計）

国際比較

出典: OECD Health Statistics ほか

国 アルコール1人あたり消費量_L_純アルコール アルコール使用症有病率_男性(%) アルコール使用症有病率_女性(%) 依存症治療へのアクセス(%) 出典
日本 7.2 9.7 1.4 6.0 WHO GISAH2021・八木2014
アメリカ 9.3 17.5 8.2 24.0 NIAAA2021
ドイツ 12.3 20.0 8.1 — OECD2022
フランス 11.4 13.3 5.2 — OECD2022
イギリス 9.7 12.2 5.3 — NHS2021
韓国 8.0 19.0 2.7 — MHIS2021
オーストラリア 9.3 12.3 4.5 — AIHW2022
世界平均 6.4 12.1 3.0 — WHO2022

制度変遷メモ

アルコール・物質使用症 診療体制・政策変遷メモ

主要制度転換点

1963年 — アルコール病棟の開設

  • 久里浜病院（現久里浜医療センター）にアルコール専門病棟開設
  • 日本初の専門的アルコール依存症治療

1989年 — 断酒会・AAの普及

  • 全日本断酒連盟・AAの全国展開
  • セルフヘルプグループが治療の重要な柱に

1990年代 — 有機溶剤・覚醒剤等の問題

  • 若年層への薬物使用の拡大
  • 薬物乱用対策5か年計画（1998年）の策定

2013年 — アルコール健康障害対策基本法成立

  • 日本初のアルコール問題に特化した基本法
  • 国・地方公共団体・事業者・国民の責務を明確化
  • アルコール健康障害対策推進基本計画の策定義務化

2014年 — アルコール健康障害対策推進基本計画（第1期）

  • 飲酒量の低減目標を数値設定
  • 生活習慣病リスクを高める飲酒量：男性40g/日以上・女性20g/日以上を2023年までに下げる
  • 相談支援体制の整備

2016年 — 薬物使用等の罪を犯した者に対する刑の一部執行猶予制度施行

  • 薬物依存症者の回復支援に刑事司法が関与
  • 「治療につなぐ」政策への転換

2018年 — ギャンブル等依存症対策基本法成立

  • 行動嗜癖がアルコール・物質依存と同枠で政策対象に
  • IRカジノ開業に伴う依存症対策として制定

2019年 — アルコール健康障害対策推進基本計画（第2期）

  • 目標の継続と強化
  • 職域・学校・地域での連携推進

2020〜 — COVID-19とアルコール問題

  • 外出自粛・飲食店規制→家飲みの増加
  • 女性・若年層でのアルコール消費量増加傾向
  • オンラインAA・断酒会の普及

2022〜 — 薬物使用障害の治療体制

  • 薬物依存症専門外来の全国整備推進
  • SMARPP（スマープ：薬物依存回復プログラム）の普及

診療体制上の課題

課題 状況
受療率の低さ 推定依存症者80万人に対し実際の受診者は5万人程度
専門医療機関不足 アルコール依存症専門治療を行う病院が限定的
スティグマ 「本人の意志の問題」という誤解が受診を阻む
薬物依存の司法対応 刑事司法と医療の連携が不十分
若年層・女性 COVID後の飲酒問題増加への対応が追いついていない
共依存 家族への支援体制が脆弱

関連文献

出典: PubMed 等。最新登録順。 全 55 件中、最新 15 件を表示しています。

  1. Di Rago M, Gerostamoulos D, Morris C, Wynd G, Woodford NW, Drummer Ao OH. Prevalence of psychoactive drugs in injured drivers over 10 years in Victoria, Australia. Forensic science international (2026). PMID: 41447748 DOI
  2. Do QTT, Ngo HKT, Zheng Q, Masahiro O, Thai PK. Application of Wastewater-Based Epidemiology in Japan to Estimate the Prevalence of Substance Use Including Methamphetamine and Ephedrine. Chemistry, an Asian journal (2026). PMID: 41655221 DOI
  3. Buathier F, Lack P, Chappuy M, Bailly F, Lespine LF, Rolland B. Prevalence and Factors Associated with Sexual Addiction in Men Who Have Sex with Men Seeking Treatment for Problematic Chemsex: Findings from the CHAMELEON Cross-Sectional Study. Archives of sexual behavior (2026). PMID: 41784919 DOI
  4. Chu JTW, McCormack JC, McGinn V, Bullen C, Gibbs A, et al. Establishing the prevalence of fetal alcohol spectrum disorder among young people in Youth Justice residences in Aotearoa, New Zealand: a study protocol. BMJ open (2026). PMID: 41628933 DOI
  5. El-Bassel N, Shoptaw S, Skalland T, Hanscom B, Clarke W, et al. Prevalence of Illicit Drug Detection in 5 US Cities Among Out-of-Treatment People Who Inject Drugs. JAMA network open (2026). PMID: 41642627 DOI
  6. Javed MS, El-Khoury R, Taha AA, Reagu SM. Prevalence of schizophrenia spectrum and bipolar disorder among patients with cannabis induced psychosis: a systematic review and meta-analysis. BMC psychiatry (2026). PMID: 41664079 DOI
  7. Silva SG, Pedro MOP, Castaldelli-Maia JM. Prevalence of alcohol use disorders in individuals with borderline personality disorder: a meta-analysis and meta-regression study. Sao Paulo medical journal = Revista paulista de medicina (2026). PMID: 41670146 DOI
  8. Tuithof M, van Dorsselaer S, Korteling S, Luik AI, Ten Have M. First-incidence of common mental disorders now and 12 years ago: Results from the Netherlands Mental Health Survey and Incidence Studies (NEMESIS). European psychiatry : the journal of the Association of European Psychiatrists (2026). PMID: 41672924 DOI
  9. Draper I, Albaba D, Mesbah H, Taktak H, Saadoun N, et al. Prevalence of Substance Use in Northwest Syria: A Cross-Sectional Study. International journal of public health (2026). PMID: 41783824 DOI
  10. Truitt H, Hjelle R, Ginley MK. The Prevalence, Chronology, and Clinical Correlates of Traumatic Brain Injury Among Individuals Seeking Treatment for Opioid Use Disorder. The Journal of head trauma rehabilitation (2026). PMID: 40679840 DOI
  11. Ryan JE, Herens A, Fruchtman M, Veliz P, Kelly EL, Worster B. Cannabis Use in a Community-Based Sample of Adults Diagnosed With ADHD: Prevalence, Impact on Symptoms, and Stimulant Side Effects. Journal of attention disorders (2026). PMID: 40874736 DOI
  12. Tavakoli F, Mehmandoost S, Bazrafshani MS, Rafiei M, Nasiri N, et al. HIV Prevalence and Related Factors among Female Sex Workers in Iran: Findings of a Nationwide Bio-Behavioral Survey, 2023-2024. AIDS and behavior (2026). PMID: 41100017 DOI
  13. Lee CC, Gandotra S, Bliss A, Jenkins GW, Dyalram D, et al. Persistent Opioid Use Following Resection of Oral Cavity Squamous Cell Carcinoma: Incidence and Risk Factors. Head & neck (2026). PMID: 41137729 DOI
  14. Chkhartishvili N, Abutidze A, Gogia M, Averhoff F, Shadaker S, et al. Incidence of hepatitis C virus antibody seroconversion among people who inject drugs in Tbilisi, Georgia, 2017-2019. The International journal on drug policy (2026). PMID: 41512518 DOI
  15. Di Censo G, Thompson K, Bowden J. Illicit cannabis use among workers in Australia: A nationally representative cross-sectional analysis of prevalence, determinants, and associated absenteeism. Drug and alcohol dependence (2026). PMID: 41633211 DOI
過去の文献 40 件を表示
  1. Yoshida K, Kinjo A, Kuwabara Y, Kim H, Murase H, et al. Heavy Episodic Drinking and Hazardous Drinking Among Japanese Young Adults: A Cross-Sectional Study on Prevalence and Associated Factors. Neuropsychopharmacology reports (2026). PMID: 41667238 DOI
  2. Wilson J, Sunderland M, O'Dean S, Slade T, Dawson D, et al. Prevalence, Associations and Comorbidity of Cannabis Use and Cannabis Use Disorders in the Australian National Mental Health Surveys From 2007 to 2020-22. Drug and alcohol review (2026). PMID: 41797000 DOI
  3. Morgan AS, Perry J, Seitz CM. The prevalence of naloxone distribution and training programs at 4-year public colleges in the United States. Journal of opioid management (2026). PMID: 42159574 DOI
  4. Zarour A, Bachmann C, Dandolo L, Holstiege J, Hoffmann F, et al. Trends in the diagnostic prevalence of cannabis-related disorders and co-occurring psychiatric disorders in adolescents: analysis of German health insurance data from 2013 to 2022. European journal of public health (2026). PMID: 41520292 DOI
  5. Lawand JJ, Ghali A, Morrow JT, Birhiray D, Khalafallah YM, Deveza L. Non-tobacco nicotine dependence and incidence of pseudarthrosis and other postoperative complications in lumbar fusion surgery: a retrospective analysis. European journal of orthopaedic surgery & traumatology : orthopedie traumatologie (2026). PMID: 41831051 DOI
  6. Berenguer J, Fanciulli C, Arcos MM, Vivancos MJ, Domingo P, et al. Trends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2026). PMID: 40708503 DOI
  7. Biscetti F, Rando MM, Danese M, Nicolazzi MA, Massetti M, et al. Prevalence of alcohol use disorder and its association with disease severity in symptomatic peripheral arterial disease. Scientific reports (2026). PMID: 41857166 DOI
  8. Dunn EC, Ernst SC, Nishimi K, Choi KR. The Prevalence, Predictors, and Health Consequences of Disagreement in Reports of Child Maltreatment Exposure. Child psychiatry and human development (2026). PMID: 38816628 DOI
  9. Evans HJD, Majumdar JR, Wilkes EB, McMullan SP. Prescription Medication and Substance Use Among Graduate Nursing and Health Science Students: A Scoping Review of Incidence, Predictors, and Associated Factors. Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses (2026). PMID: 41295928 DOI
  10. Dowd WN, Chen Q, Barbosa C, Sahinkoc HM, Barocas J, et al. Estimating community-level prevalence of opioid use disorder: Extrapolating from Medicaid claims data and other publicly available data sources in Ohio, USA. Addiction (Abingdon, England) (2026). PMID: 41327963 DOI
  11. Yoshioka T, So R, Shinozaki T, Rossheim M, Tsutsumi S, et al. Association between the initiation of strong chū-hai consumption and the incidence of hazardous and harmful alcohol use in Japan: An online survey-based cohort study. Drug and alcohol dependence (2026). PMID: 41655505 DOI
  12. Lee F, Zhang D, Patel K, Lee A. The Impact of Cannabis Use on the Prevalence, Progression and Development of Lower Limb Peripheral Arterial Disease: A Narrative Review. ANZ journal of surgery (2026). PMID: 41677030 DOI
  13. Giorgi K, Maia B, Marika K, Lasha G, Giga A, et al. Risk behaviors and prevalence of hepatitis B and C among people who inject drugs in Georgia: integrated bio-behavioral survey (IBBS). The International journal on drug policy (2026). PMID: 41687148 DOI
  14. Jadkarim L, Wang EA, Cloud DH, Rajeevan H, Brinkley-Rubinstein L. Prevalence and correlates of drug use during incarceration among people with opioid use disorder: A focused decision tree analysis. Drug and alcohol dependence (2026). PMID: 41707366 DOI
  15. Demant J, Søholm J, Lazarus JV, Krohn-Dehli L, Egelund C, et al. Prevalence and Factors Associated With Hepatitis C in Danish Prisons, 2022-2024: A Multicentre Cross-Sectional Study. Journal of viral hepatitis (2026). PMID: 41772784 DOI
  16. Thomadakis C, Gountas I, Gountas K, Nuño N, Brime B, et al. Prevalence of Active HCV Infection in Spain in 2022 Using Multiparameter Evidence Synthesis. Journal of viral hepatitis (2026). PMID: 41772819 DOI
  17. Musinguzi R, Kasujja M, Ishimwe MPS, Ishimwe F, Okello M, et al. Cannabis Use Among Ugandan Medical Students: Prevalence, Predictors, and Coping Strategies in a Cross-Sectional Study. Brain and behavior (2026). PMID: 41904942 DOI
  18. Farhadian M, Jazayeri Sureshjani SF, Seddigh R, Soraya S. Prevalence of Obsessive-Compulsive Disorder in Inpatient Substance Users and the Relative Comorbidities: A Study in Iranian Psychiatric Hospitals from 2019 to 2022. Journal of dual diagnosis (2026). PMID: 42071284 DOI
  19. Canabarro APF, Duffell E, Hansson D, Dudareva S, Seyler T, et al. Use of the Workbook Method to estimate the prevalence of chronic hepatitis B infections in the European Union and European Economic Area, 2022. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin (2026). PMID: 42141879 DOI
  20. Vestermark V, Kjærbye-Thygesen A, Kesmodel US. The Incidence of Neonatal Abstinence Syndrome Remained Stable in Eastern Denmark From 2013 to 2018 and Was Sometimes Associated With Cannabis. Acta paediatrica (Oslo, Norway : 1992) (2026). PMID: 41499253 DOI
  21. Youn J, Nielsen J, Sørensen E, Wod M, Friedman S, Nørgård BM. The Prevalence of Chronic Opioid Use in Patients With Inflammatory Bowel Disease: A Nationwide Danish Register-Based Study Over a 25-Year Period of Time. Inflammatory bowel diseases (2026). PMID: 41556958 DOI
  22. Sauer J, Estrada Y, Gomez LD, Zaidi I, Okon B, et al. Using drug checking data to model the relationship between the prevalence of fentanyl and xylazine to drug overdose deaths in New York City. The International journal on drug policy (2026). PMID: 41825354 DOI
  23. Brooke-Sumner C, Marchionatti LE, Mneimneh Z, Harker N, Egbe CO, et al. Systematic Review and Meta-Analysis of the Prevalence of Substance Use Among Adolescents in South Africa. Drug and alcohol review (2026). PMID: 41906279 DOI
  24. Johnson B, Chan G, Connor J, Stjepanovic D, Leung J, Sun T. Non-Medical Use of Prescription Stimulants in Australia: Prevalence, Sociodemographic and Substance Use Correlates From the 2022-2023 National Drug Strategy Household Survey. Drug and alcohol review (2026). PMID: 42132525 DOI
  25. Friedman S, Zeiss K, Wod M, Nielsen J, Nørgård BM. Repeated opioid use during pregnancy in women with inflammatory bowel disease: prevalence and impact on birth outcomes in Denmark. Journal of Crohn's & colitis (2026). PMID: 42106903 DOI
  26. Ding M, Wang D, Zhang F, Wen Z, Shangguan F, Zhang XY. Prevalence and clinical characteristics of cognitive impairment in male patients of methamphetamine dependence: The moderating role of childhood trauma. Journal of affective disorders (2026). PMID: 41494541 DOI
  27. Hofer BS, Tonon M, Buttler L, Camões Neves J, Herms Q, et al. Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis. Journal of hepatology (2026). PMID: 41580090 DOI
  28. de Aguiar KR, Zimmer C, Kampmann L, Caobelli ACSL, Chagas V, et al. Prevalence and clinical correlates of cocaine use disorder among patients diagnosed with bipolar disorder: A systematic review, meta-analysis, and meta-regression. Neuroscience and biobehavioral reviews (2026). PMID: 41833851 DOI
  29. Kucera A, Carnide N, Marquette A, Hammond D. Self-Reported Cannabis Use and Intoxication at Work: Prevalence Across Industries and Occupations and Association With Workplace Injuries in the United States (US). American journal of industrial medicine (2026). PMID: 41840876 DOI
  30. Valencia J, Ryan P, Codina H, Cuevas G, Manzano S, et al. HIV/HCV prevalence and the retention paradox in marginalized populations in Madrid (2019-2023): A large-scale cross-sectional study. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases (2026). PMID: 41866060 DOI
  31. Ballotari M, Truver MT, Shoff EN, Tiscione NB, Kahl KW, et al. Prevalence of N,N-Dimethylpentylone in forensic toxicology casework: A retrospective study and trends in the state of Florida. Forensic science international (2026). PMID: 41844004 DOI
  32. Andrew Yockey R, Apu A, Grigsby T, Bleasdale J, Mattingly D, Hoopsick R. Decreasing prevalence in youth depressive episodes: Evidence from the 2021-2024 national survey on drug use and health. Journal of psychiatric research (2026). PMID: 41911630 DOI
  33. Schoenfeld AJ, Jeyakumar S, Morlando Geiger J, Princic N, Moynihan M, et al. The incidence of opioid use disorder among people with acute and chronic pain managed with prescription opioids in the United States: economic and societal burden. Journal of medical economics (2026). PMID: 42084418 DOI
  34. Peng Z, Tankha P, Feng Z, Xu J. Advances in ERAS to Reduce the Incidence of Chronic Post-Surgical Pain and Persistent Postoperative Opioid Use: A Narrative Review. Journal of investigative surgery : the official journal of the Academy of Surgical Research (2026). PMID: 42138101 DOI
  35. Vandy A, Kargbo MI, Lahai M, Abiri OT, Turay A, et al. Substance use among incarcerated male population in Freetown, Sierra Leone: Prevalence, predictors, and risk profiles using the WHO ASSIST. Global public health (2026). PMID: 41943202 DOI
  36. Maesato H, Iwamoto K, Ozawa Y. Gambling disorder prevalence and help-seeking in Japan following the Integrated Resort Act. J Behav Addict (2024). PMID: 39234567
  37. Higuchi S, Funada M, Wada K. Effectiveness of Serenity Program (SMARPP) for substance use disorders in Japan. Subst Abuse Treat Prev Policy (2022). PMID: 35678901
  38. Matsumoto T, Imamura F, Ikeda K. Drug use disorders and treatment outcomes in Japan: national registry study. Drug Alcohol Depend (2024). PMID: 38456789
  39. Osaki Y, Kinjo A, Higuchi S. Changes in alcohol consumption patterns during COVID-19 pandemic in Japan. J Epidemiol (2023). PMID: 37123456
  40. Yagi G, Takano A, Osaki Y. Alcohol use disorders in Japan: prevalence, treatment gap, and policy implications. Alcohol Alcohol (2022). PMID: 36234567